BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10592714)

  • 21. Multidrug resistance in yeast Candida.
    Prasad R; Kapoor K
    Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.
    Silva DB; Rodrigues LM; Almeida AA; Oliveira KM; Grisolia AB
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):192-9. PubMed ID: 26982177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts.
    Accoceberry I; Rougeron A; Biteau N; Chevrel P; Fitton-Ouhabi V; Noël T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adhesion of Candida species to epithelial surfaces.
    Douglas LJ
    Crit Rev Microbiol; 1987; 15(1):27-43. PubMed ID: 3319419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence and biofilm formation of non-Candida albicans Candida species.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    Trends Microbiol; 2011 May; 19(5):241-7. PubMed ID: 21411325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-adhesin antibodies that recognize a receptor-binding motif (adhesintope) inhibit pilus/fimbrial-mediated adherence of Pseudomonas aeruginosa and Candida albicans to asialo-GM1 receptors and human buccal epithelial cell surface receptors.
    Lee KK; Yu L; Macdonald DL; Paranchych W; Hodges RS; Irvin RT
    Can J Microbiol; 1996 May; 42(5):479-86. PubMed ID: 8640607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
    Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
    Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates.
    Xu Y; Sheng F; Zhao J; Chen L; Li C
    Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
    Yang L; Su MQ; Ma YY; Xin YJ; Han RB; Zhang R; Wen J; Hao XK
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease.
    Gyles C; Boerlin P
    Vet Pathol; 2014 Mar; 51(2):328-40. PubMed ID: 24318976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Are there pathogenicity factors in fungi?].
    Morschhäuser J; Köhler G; Hacker J
    Mycoses; 1996; 39 Suppl 1():51-4. PubMed ID: 8767271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The KEX2 gene of Candida glabrata is required for cell surface integrity.
    Bader O; Schaller M; Klein S; Kukula J; Haack K; Mühlschlegel F; Korting HC; Schäfer W; Hube B
    Mol Microbiol; 2001 Sep; 41(6):1431-44. PubMed ID: 11580846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
    Coste A; Selmecki A; Forche A; Diogo D; Bougnoux ME; d'Enfert C; Berman J; Sanglard D
    Eukaryot Cell; 2007 Oct; 6(10):1889-904. PubMed ID: 17693596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.